BMP9 Potentiates Immunotherapy in Triple-Negative Breast Cancer by Suppressing Tregs Infiltration via the PRKDC-CCL2 Axis
{{output}}
Immunotherapy represents a pivotal strategy for triple-negative breast cancer (TNBC), yet its efficacy is constrained by the immunosuppressive tumor microenvironment (TME). In this study, we demonstrate that bone morphogenetic protein-9 (BMP9) inhibits tumor g... ...
